Molecular BiologybioRxivPreprint
MEK signaling represents a viable therapeutic vulnerability of KRAS-driven somatic brain arteriovenous malformations
Carlos Perfecto Flores Suarez, Omar Ashraf Harb, Ariadna Robledo…·Joshua D. Wythe
This study shows that KRAS mutations drive brain arteriovenous malformations (bAVMs) in specific brain regions and that MEK inhibition can reduce their severity in mice, suggesting a potential therapeutic approach for human bAVMs.